DiaMedica Therapeutics
DMAC
DMAC
45 hedge funds and large institutions have $36.5M invested in DiaMedica Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 40 → 45 (+5)
2.68% more ownership
Funds ownership: 13.05% → 15.74% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
45
Holding in Top 10
1
Calls
$264K
Puts
$6K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.05M | |
| 3 | +$615K | |
| 4 |
6CM
683 Capital Management
New York
|
+$413K |
| 5 |
Goldman Sachs
New York
|
+$374K |
Top Sellers
| 1 | -$123K | |
| 2 | -$59.6K | |
| 3 | -$39.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$15K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$13.7K |